Update in pmos
Asking for Preferences
PMOS - obs gyn
Reading File
Searching the Web
PMOS obstetrics gynecology medical abbreviation 2025 2026
Reading Web Page
https://www.contemporaryobgyn.net/view/global-consensus-rena…
Searching PubMed
polyendocrine metabolic ovarian syndrome PMOS PCOS rename
Finding Sources
Excellent - now I have a comprehensive picture. Here is the full update:
PMOS - The New Name for PCOS (OB-GYN Update, 2026)
What Is PMOS?
PMOS = Polyendocrine Metabolic Ovarian Syndrome
This is the new official name for what was previously called Polycystic Ovary Syndrome (PCOS). The renaming was published in The Lancet on May 12, 2026 following what the authors described as an "unprecedented, rigorous, multistep global consensus process" led by Teede HJ, Khomami MB, Morman R, et al.
Why the Name Was Changed
The term "Polycystic Ovary Syndrome" was deemed problematic for several reasons:
- Inaccurate - implies pathological ovarian cysts, which not everyone with the condition develops
- Misleading - fails to reflect the diverse endocrine and metabolic features of the condition
- Contributes to delayed diagnosis - fragmented care and stigma
- Limits research and policy framing - by narrowly framing the condition as ovarian/structural
The new name was selected to better reflect the condition's true pathophysiology.
What Each Word in "PMOS" Means
| Term | Meaning |
|---|---|
| Poly | Multiple systems involved |
| Endocrine | Multiple hormone axes affected (not just reproductive) |
| Metabolic | Insulin resistance, diabetes risk, cardiovascular risk are central features |
| Ovarian | Acknowledges the ovarian component |
| Syndrome | A clinical syndrome with diverse presentations |
What Does NOT Change
Diagnosis still relies on the same combination of clinical features:
- Irregular or absent periods (oligo/anovulation)
- Signs of elevated androgens (hirsutism, acne, hair loss)
- Ovarian changes on ultrasound (follicular pattern)
Treatment principles remain the same - symptom management, fertility support, and long-term metabolic health monitoring.
What Will Change Over Time
- Greater emphasis on metabolic screening: blood glucose, lipids, blood pressure, cardiovascular risk factors
- Earlier intervention: broader framing may help clinicians recognize and act sooner
- More integrated management plans: addressing not just fertility/periods but long-term cardiometabolic health
- Research and policy: funding, guidelines, and advocacy framing will shift to reflect the metabolic-endocrine complexity
Transition Timeline
The consensus states transition to the new name will occur over 3 years, supported by a multifaceted global implementation and evaluation strategy. Until then, both "PCOS" and "PMOS" refer to the same condition - expect to see both used interchangeably in clinical practice for some time.
Key Epidemiology (Unchanged)
- Affects approximately 1 in 10 women of reproductive age
- One of the most common hormonal disorders globally
- Often goes undiagnosed or misunderstood for years due to diverse presentations
Recent PubMed Publications on PMOS (2026)
Several papers have already been published responding to this change:
- [PMID 42454868] - "What's in a name: the potential impact of the updated terminology of PMOS" - Expert Rev Mol Diagn, July 17, 2026
- [PMID 42372905] - "From PCOS to PMOS: Implications for Adolescent Gynecologic Care" - J Pediatr Adolesc Gynecol, June 29, 2026
- [PMID 42327014] - "From PCOS to PMOS: A metabolic reframing, promise, controversies, and challenges ahead" - Metabol Open, June 2026
- [PMID 42427099] - "PCOS/PMOS Research Underfunding Continues" - J Clin Endocrinol Metab, July 10, 2026
Summary
PCOS is now PMOS. The condition is the same; the name better captures the reality that this is a multi-hormonal, metabolic disorder - not just an ovarian structural problem. The diagnostic criteria and treatment are unchanged for now, but expect evolving guidelines to place greater weight on cardiometabolic risk management.
This is a shared conversation. Sign in to Orris to start your own chat.